Matrix Capital Management Company, LP

Insider Reports History

Location
Portsmouth, NH
Signature
Matrix Capital Management Company, LP, by: /s/ David E. Goel, its Managing General Partner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matrix Capital Management Company, LP:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zentalis Pharmaceuticals, Inc. 10%+ Owner Common Stock, par value $0.001 per share 14M $144M $10.29 20 Jun 2023 Indirect
Aura Biosciences, Inc. 10%+ Owner Common Stock, par value $0.00001 per share (Common Stock) 6.92M $62.3M $9.00 09 Nov 2023 Indirect

Insider Reports Filed by Matrix Capital Management Company, LP

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AURA Aura Biosciences, Inc. 09 Nov 2023 1 $14M 4 09 Nov 2023 10%+ Owner
ZNTL Zentalis Pharmaceuticals, Inc. 20 Jun 2023 1 $108M 4 20 Jun 2023 10%+ Owner
AURA Aura Biosciences, Inc. 05 Dec 2022 1 $15M 4 07 Dec 2022 10%+ Owner
ZNTL Zentalis Pharmaceuticals, Inc. 18 May 2022 0 $0 3 03 Jun 2022 10%+ Owner
AURA Aura Biosciences, Inc. 02 Nov 2021 3 $25M 4 04 Nov 2021 10%+ Owner
AURA Aura Biosciences, Inc. 28 Oct 2021 0 $0 3 28 Oct 2021 10%+ Owner